ABEO logo

ABEO
Abeona Therapeutics Inc

11,020
Mkt Cap
$287.21M
Volume
347,628.00
52W High
$7.54
52W Low
$3.93
PE Ratio
4.55
ABEO Fundamentals
Price
$5.46
Prev Close
$5.30
Open
$5.34
50D MA
$4.94
Beta
0.73
Avg. Volume
2.69M
EPS (Annual)
-$1.55
P/B
1.62
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Boone Capital Management LLC Makes New Investment in Abeona Therapeutics Inc. $ABEO
Boone Capital Management LLC acquired a new stake in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) during the second quarter, according to its most recent disclosure with the...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Below Two Hundred Day Moving Average - Time to Sell?
Abeona Therapeutics (NASDAQ:ABEO) Shares Pass Below 200-Day Moving Average - What's Next...
MarketBeat·11d ago
News Placeholder
ABEO FY2025 EPS Forecast Lifted by Cantor Fitzgerald
Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) - Cantor Fitzgerald raised their FY2025 EPS estimates for Abeona Therapeutics in a report released on Tuesday, November 25th. Cantor Fitzgerald...
MarketBeat·26d ago
News Placeholder
Mark Alvino Sells 15,000 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock
Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) Director Mark Alvino sold 15,000 shares of the firm's stock in a transaction on Thursday, November 13th. The stock was sold at an average...
MarketBeat·1mo ago
News Placeholder
Abeona Therapeutics (NASDAQ:ABEO) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut Abeona Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·1mo ago
News Placeholder
Abeona Therapeutics (NASDAQ:ABEO) Director Mark Alvino Sells 15,000 Shares
Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) Director Mark Alvino sold 15,000 shares of the firm's stock in a transaction dated Thursday, November 13th. The stock was sold at an average...
MarketBeat·1mo ago
News Placeholder
Abeona Therapeutics (NASDAQ:ABEO) Posts Quarterly Earnings Results
Abeona Therapeutics (NASDAQ:ABEO - Get Free Report) announced its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.10) EPS for the quarter, topping analysts...
MarketBeat·1mo ago
News Placeholder
Nan Fung Trinity HK Ltd. Invests $3.19 Million in Abeona Therapeutics Inc. $ABEO
Nan Fung Trinity HK Ltd. purchased a new stake in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·1mo ago
News Placeholder
Abeona Therapeutics Inc. $ABEO Shares Purchased by Simplify Asset Management Inc.
Simplify Asset Management Inc. boosted its stake in Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) by 36.7% during the 2nd quarter, according to its most recent Form 13F filing with the...
MarketBeat·1mo ago
News Placeholder
Los Angeles Capital Management LLC Takes Position in Abeona Therapeutics Inc. $ABEO
Los Angeles Capital Management LLC bought a new position in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the...
MarketBeat·1mo ago
<
1
2
...
>

Latest ABEO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.